Replies to post #74000 on Ayala Pharmaceuticals Inc (ADXS)

[James salmon]

Not a chance we will be anywhere near that amount of shares.

Now just say worst case scenario we have to dilute to survive, without any news on HOT, NEO, AXAL, milestone payments or partnerships that would increase share price, which is highly unlikely.

Current spend is 50 million a year, with probably around 10 million a year from Amgen.

So we have to find 40 million a year say for no more than 4 years. We already have 50 million which covers off the first year, and we would have to find 120 million.

Even if we only got $1 a share we would add 120 million to share count, so you're post is laughable when you try to suggest 2 billion in shares.

[biotech_researcher]

Barrel, I don’t think you can say this as it is many years out: “I agree, still a very good chance that the science will pan out with a product..”